Accessibility Menu
 

Vertex Pharmaceuticals Nabs Key FDA Approval in Cystic Fibrosis

The Food and Drug Administration has expanded eligibility for Trikafta to include amenable cystic fibrosis patients aged 6 to 11.

By Todd Campbell Jun 9, 2021 at 2:37PM EST

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.